Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gilead Keeps Close Eye On Stormy Remdesivir Situation In India

Apr 19 2021

• By Anju Ghangurde

SC1806_After Storm_201725048_1200.jpg — Gilead Keeps Close Eye On Remedesivir India Saga • Source: Shutterstock

Related Content

Coronavirus Notebook: EU To Buy 30 Million Doses Of Valneva Vaccine, Russia To Issue Compulsory License For Remdesivir

Jan 14 2021

India Remdesivir Saga: Exports Barred, Ramp Up Plans And Panic

Apr 13 2021

Pandemic Perspectives: Remdesivir, Favipiravir’s Eventful Journeys In India A Year On

Mar 17 2021

Related Companies

Gilead Sciences, Inc.

Dr. Reddy's Laboratories Ltd.

Cipla Limited

Hetero Drugs Ltd.

Mylan Pharmaceuticals Inc.

Syngene International Ltd.

Zydus Lifesciences Limited

Additional Topics

India Asia Pacific Commercial Coronavirus COVID-19 BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window